Navigation Links
Par Pharmaceutical Reports Second Quarter 2008 Results
Date:8/7/2008

505 -

Provision for income taxes 268 - 713 -

Loss from discontinued

operations 268 - 208 -

Net (loss) income ($20,063) $2,798 ($17,477) $44,312

Basic (loss) earnings

per share of common

stock:

(Loss) income from

continuing operations ($0.59) $0.08 ($0.52) $1.28

Loss from discontinued

operations (0.01) - ($0.01) -

Net (loss) income ($0.60) $0.08 ($0.53) $1.28

Diluted (loss) earnings

per share of common stock:

(Loss) income from

continuing operations ($0.59) $0.08 ($0.52) $1.27

Loss from discontinued

operations (0.01) - (0.01) -

Net (loss) income ($0.60) $0.08 ($0.53) $1.27

Weighted average number of

common shares outstanding:

Basic 33,304 34,676 33,262 34,647

Diluted 33,304 34,943 33,262 34,970


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Memory Pharmaceuticals to Announce Second Quarter 2008 Results on Wednesday, August 13, 2008
3. Watson Pharmaceuticals Reports Second Quarter 2008 Results
4. XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies
5. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
6. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
7. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
8. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
10. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
11. Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (PRWEB) February 26, 2015 The ... -12, at the Ernest N. Morial Convention Center ... (count as of February 19, 2015) displaying products ... industrial, academic, and government labs. The Exposition will ... but not limited to, analytical chemistry; drug discovery; ...
(Date:2/26/2015)... JUPITER, Fla. , Feb. 26, 2015 /PRNewswire/ ... biotechnology company whose patented and proprietary technologies are ... other proteins for the bioenergy, bio-based chemical, biopharmaceutical ... will report its financial results for year ending ... March 11, 2015 and will host a conference ...
(Date:2/26/2015)... 26, 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... at the Cowen 35 th Annual Health Care Conference ... Boston .  Lexicon management will provide an ... A webcast of the presentation will be available through Lexicon,s ... presentation will be available at www.lexpharma.com until April ...
(Date:2/26/2015)... LONDON , February 26, 2015 ... of subjects into PEACH, the first pivotal trial ... dialysis dependent chronic kidney disease (DD-CKD), has completed ... achieved. PT20, invented by leading UK-based ... licensed by Phosphate Therapeutics, is a novel phosphate ...
Breaking Biology Technology:Pittcon 2015 Announces Exposition Highlights 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3Lexicon To Present At The Cowen 35th Annual Health Care Conference 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3
... announced on Tuesday that they have signed an agreement ... system CardioIMS. The system will be implemented in the ... needs of children and adults with hereditary heart defects. ... of the Center's administrative and clinical needs, looking specifically ...
... computer science department The Internet may have become ... seminar Tuesday evening held by the University of Wisconsin-Madison's ... commercial Internet is no longer friendly to experimentation. , ... department, directs PlanetLab , a distributed network of ...
... University of Wisconsin-Madison will lead 21 state colleges in ... in science, technology, engineering and math, the university has ... four-year universities and two-year colleges from around the state. ... program of the National Science Foundation, contributed a $2.5 ...
Cached Biology Technology:Children's Hospital chooses Camtronics for cardiology IT system 2UW attracts speaker on network that could supplant Internet 2UW attracts speaker on network that could supplant Internet 3UW attracts speaker on network that could supplant Internet 4
(Date:2/9/2015)... Feb. 9, 2015  Lintec of America recently announced ... carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, ... Leveraging the vast industrial resources of the ... , Lintec of America is forming the Nano-Science ... , focusing on scaling up the manufacturing and ...
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces the ... as part of its 2015 marketing and branding initiatives ... new consumer website for Wocketwallet.com earlier this month. ... said, "Our new corporate website naturally showcases our premiere ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... trials for a vaccine against Streptococcus A, the germ that ... heart is just one of the possible long term consequences ... had heart surgery to repair damage suffered from rheumatic fever ... Good, Principal Research Leader at the Institute for Glycomics has ...
... Bethesda, MDWomen who are pregnant or using synthetic progesterone ... infections including malaria, Listeria, HIV, and herpes simplex virus. ... issue of the Journal of Leukocyte Biology ... the progesterone receptor, a pregnancy hormone sensor, targets a ...
... Researchers at Wake Forest Baptist Medical Center and ... cells in bone marrow that have the natural ability ... suggesting their potential to restore healthy tissue in patients ... million Americans have IBD, which is characterized by frequent ...
Cached Biology News:Progesterone may be why pregnant women are more vulnerable to certain infections 2Research supports promise of cell therapy for bowel disease 2
DTT, 25g...
... Agarose overlays are commonly ... Many commercial "DNA grade" agaroses ... toxic to insect cells or ... to obtain good overlays. Novagen's ...
Antibody specific for trimethyl-Lys27 of histone H3. Mouse monoclonal. Antigen: Synthetic peptide derived from histone H3, trimethylated at lysine 27...
...
Biology Products: